Lovastatin
- Product NDC
- 45963-635
- 11-digit product format
- 459630635
- Labeler code
- 45963
- Product ID
- 45963-635_fa0b909d-8e24-416d-9674-b18bb436e657
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lovastatin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Actavis Pharma, Inc.
- Application
- ANDA075828
- Marketing category
- ANDA
- Marketing start
- 2001-12-17
- Marketing end
- 2021-03-31
- Substance
- LOVASTATIN
- Active strength
- 40 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 45963-635-01 | 45963063501 | 60 TABLET in 1 BOTTLE (45963-635-01) | 60 tablet | 2011-09-26 | 2021-02-28 | No | No | Current |
| 45963-635-04 | 45963063504 | 500 TABLET in 1 BOTTLE (45963-635-04) | 500 tablet | 2001-12-17 | 2021-03-31 | No | No | Current |